Cargando…

HSPA8 Is a New Biomarker of Triple Negative Breast Cancer Related to Prognosis and Immune Infiltration

OBJECTIVE: Triple negative breast cancer (TNBC) is a kind of cancer that endangers the lives of women all over the world in the 21st century. Heat shock protein member 8 (HSPA8) is the chaperone gene of the heat shock protein family. It is involved in many cellular functions. For example, it promote...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ying, Bicheng, Xu, Wenting, Nie, Yan, Li, Yongtao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9705114/ https://www.ncbi.nlm.nih.gov/pubmed/36452344 http://dx.doi.org/10.1155/2022/8446857

Ejemplares similares

HSPA1A, HSPA2, and HSPA8 Are Potential Molecular Biomarkers for Prognosis among HSP70 Family in Alzheimer's Disease
por: Dong, Yeqing, et al.
Publicado: (2022)

HSPA5 Could Be a Prognostic Biomarker Correlated with Immune Infiltration in Breast Cancer
por: Zhang, Chao, et al.
Publicado: (2022)

Tumor infiltrating lymphocytes (TILs) are a prognosis biomarker in Colombian patients with triple negative breast cancer
por: Huertas-Caro, Carlos A., et al.
Publicado: (2023)

Evaluation of triple negative breast cancer with heterogeneous immune infiltration
por: Quintana, Ángela, et al.
Publicado: (2023)

HNRNPA2B1 is a potential biomarker of breast cancer related to prognosis and immune infiltration
por: Ayoufu, Aisikeer, et al.
Publicado: (2023)

CXCR2 Levels Correlate with Immune Infiltration and a Better Prognosis of Triple-Negative Breast Cancers
por: Boissière-Michot, Florence, et al.
Publicado: (2021)

Association of CD206 Protein Expression with Immune Infiltration and Prognosis in Patients with Triple-Negative Breast Cancer
por: Bobrie, Angélique, et al.
Publicado: (2022)

ARNTL2 is a Prognostic Biomarker and Correlates with Immune Cell Infiltration in Triple-Negative Breast Cancer
por: Wang, Xiaoyu, et al.
Publicado: (2021)

Immune Cell Infiltration-Based Characterization of Triple-Negative Breast Cancer Predicts Prognosis and Chemotherapy Response Markers
por: Lv, Yufei, et al.
Publicado: (2021)

Arginine regulates HSPA5/BiP translation through ribosome pausing in triple-negative breast cancer cells
por: Vidal, Christina M., et al.
Publicado: (2023)

Immune-related biomarkers in triple-negative breast cancer
por: Zhang, Juan, et al.
Publicado: (2021)

Tumor-Infiltrating Lymphocytes in Triple Negative Breast Cancer: The Future of Immune Targeting
por: García-Teijido, Paula, et al.
Publicado: (2016)

Immune Lymphocyte Infiltrate and its Prognostic Value in Triple-Negative Breast Cancer
por: Huertas-Caro, Carlos Alexander, et al.
Publicado: (2022)

Rates of immune cell infiltration in patients with triple-negative breast cancer by molecular subtype
por: Harano, Kenichi, et al.
Publicado: (2018)

CXCL9 Is a Potential Biomarker of Immune Infiltration Associated With Favorable Prognosis in ER-Negative Breast Cancer
por: Liang, Yuan-ke, et al.
Publicado: (2021)

Pseudogene HSPA7 is a poor prognostic biomarker in Kidney Renal Clear Cell Carcinoma (KIRC) and correlated with immune infiltrates
por: Ding, Chunjin, et al.
Publicado: (2021)

Tumor-infiltrating B cells and T cells correlate with postoperative prognosis in triple-negative carcinoma of the breast
por: Kuroda, Hajime, et al.
Publicado: (2021)

LncRNAs as new biomarkers to differentiate triple negative breast cancer from non-triple negative breast cancer
por: Lv, Mingming, et al.
Publicado: (2016)

Significant correlation between HSPA4 and prognosis and immune regulation in hepatocellular carcinoma
por: Shang, Bing-Bing, et al.
Publicado: (2021)

Overexpression of PKMYT1 associated with poor prognosis and immune infiltration may serve as a target in triple-negative breast cancer
por: Li, Huihui, et al.
Publicado: (2023)

Tumor-infiltrating lymphocytes and CD8(+) T cells predict survival of triple-negative breast cancer
por: Vihervuori, H., et al.
Publicado: (2019)

Prognostic value of CD8 + PD-1+ immune infiltrates and PDCD1 gene expression in triple negative breast cancer
por: Yeong, Joe, et al.
Publicado: (2019)

Stratification of Prognosis of Triple-Negative Breast Cancer Patients Using Combinatorial Biomarkers
por: Yue, Yong, et al.
Publicado: (2016)

The Effect of the Histone Chaperones HSPA8 and DEK on Tumor Immunity in Hepatocellular Carcinoma
por: Yang, Chuanxin, et al.
Publicado: (2023)

Multi-panel immunofluorescence analysis of tumor infiltrating lymphocytes in triple negative breast cancer: Evolution of tumor immune profiles and patient prognosis
por: He, Ting-Fang, et al.
Publicado: (2020)

Heparanase is a novel biomarker for immune infiltration and prognosis in breast cancer
por: Yang, Wen-Jing, et al.
Publicado: (2021)

Upregulation of HSPA1A/HSPA1B/HSPA7 and Downregulation of HSPA9 Were Related to Poor Survival in Colon Cancer
por: Guan, Yufeng, et al.
Publicado: (2021)

New Biomarkers and Treatment Advances in Triple-Negative Breast Cancer
por: El Hejjioui, Brahim, et al.
Publicado: (2023)

Increased Tumour Infiltration of CD4+ and CD8+ T-Lymphocytes in Patients with Triple Negative Breast Cancer Suggests Susceptibility to Immune Therapy
por: Sikandar, Bushra, et al.
Publicado: (2017)

Development of an immune-related prognostic biomarker for triple-negative breast cancer
por: Zhang, Yan, et al.
Publicado: (2022)

Comparison of Clinicopathological Features and Prognosis in Triple-Negative and Non-Triple Negative Breast Cancer
por: Qiu, Jingdan, et al.
Publicado: (2016)

Role of ICAM1 in tumor immunity and prognosis of triple-negative breast cancer
por: Zhou, Qin, et al.
Publicado: (2023)

Integrated bioinformatic analysis of potential biomarkers of poor prognosis in triple-negative breast cancer
por: Bissanum, Rassanee, et al.
Publicado: (2022)

Sphingosine-1-Phosphate Catabolizing Enzymes Predict Better Prognosis in Triple-Negative Breast Cancer Patients and Correlates With Tumor-Infiltrating Immune Cells
por: Nema, Rajeev, et al.
Publicado: (2021)

CD8 T Cell Score as a Prognostic Biomarker for Triple Negative Breast Cancer
por: Oshi, Masanori, et al.
Publicado: (2020)

Clinicopathological Correlates of γδ T Cell Infiltration in Triple-Negative Breast Cancer
por: Boissière-Michot, Florence, et al.
Publicado: (2021)

Prognostic Significance of Lymphocyte Infiltrate Localization in Triple-Negative Breast Cancer
por: Čeprnja, Toni, et al.
Publicado: (2022)

Advances in Tumour-Infiltrating Lymphocytes for Triple-Negative Breast Cancer Management
por: Gorenšek, Rok, et al.
Publicado: (2023)

HSPA1A, HSPA1L and TRAP1 heat shock genes may be associated with prognosis in ovarian epithelial cancer
por: De Andrade, Warne Pedro, et al.
Publicado: (2020)

Clinical features and prognosis of triple-negative breast cancer
por: Sanz, M Izquierdo, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_ltrkl0s69u335q9t79f6nmebl7